Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment

BACKGROUND: In solid organ transplant (SOT) recipients, transplant rejection during immune checkpoint inhibitor (ICI) treatment for cancer is a clinical problem. Donor-derived cell-free DNA (dd-cfDNA) can be detected in blood and is a sensitive biomarker for diagnosis of acute rejection in SOT recip...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurkmans, Daan P., Verhoeven, Jeroen G. H. P., de Leur, Kitty, Boer, Karin, Joosse, Arjen, Baan, Carla C., von der Thüsen, Jan H., van Schaik, Ron H. N., Mathijssen, Ron H. J., van der Veldt, Astrid A. M., Hesselink, Dennis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626432/
https://www.ncbi.nlm.nih.gov/pubmed/31300068
http://dx.doi.org/10.1186/s40425-019-0653-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626432/
https://www.ncbi.nlm.nih.gov/pubmed/31300068
http://dx.doi.org/10.1186/s40425-019-0653-6

Ejemplares similares